Luc Camoin

Hepatocyte pathway alterations in response to in vitro Crimean Congo hemorrhagic fever virus infection.

Identification of new mechanisms of cellular response to chemotherapy by tracking changes in post-translational modifications by ubiquitin and ubiquitin-like proteins.

Regulatory O-GlcNAcylation sites on FoxO1 are yet to be identified.

Quantitative proteomic analysis exploring progression of colorectal cancer: Modulation of the serpin family.

The scaffolding function of the RLTPR protein explains its essential role for CD28 co-stimulation in mouse and human T cells.

How may targeted proteomics complement genomic data in breast cancer?

Regulation of NUB1 Activity through Non-Proteolytic Mdm2-Mediated Ubiquitination.

Fibronectin-guided migration of carcinoma collectives.

EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions.

Cyclipostins and cyclophostin analogs inhibit the antigen 85C from both and .

Activation peptide of the coagulation factor XIII (AP-F13A1) as a new biomarker for the screening of colorectal cancer.

Mapping Cellular Polarity Networks Using Mass Spectrometry-based Strategies.

O-GlcNAcylation site mapping by (azide-alkyne) click chemistry and mass spectrometry following intensive fractionation of skeletal muscle cells proteins.

Oxadiazolone derivatives, new promising multi-target inhibitors against M. tuberculosis.

Biochemical and Structural Characterization of TesA, a Major Thioesterase Required for Outer-Envelope Lipid Biosynthesis in Mycobacterium tuberculosis.

Development of parallel reaction monitoring (PRM)-based quantitative proteomics applied to HER2-Positive breast cancer.

Cyclipostins and Cyclophostin Analogues as Multitarget Inhibitors That Impair Growth of .

PML hyposumoylation is responsible for the resistance of pancreatic cancer.

Epigenetic down-regulation of the HIST1 locus predicts better prognosis in acute myeloid leukemia with NPM1 mutation.

Clustering as a Means To Control Nitrate Respiration Efficiency and Toxicity in Escherichia coli.

Integrative proteomic and phosphoproteomic profiling of prostate cell lines.